Investor mix
16 investors on record; lead investors include InterVest; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 44% |
| Private equity | 5 | 31% |
| Other / undisclosed | 4 | 25% |
Developer of antibodies for the treatment of multiple diseases
16 investors on record; lead investors include InterVest; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 44% |
| Private equity | 5 | 31% |
| Other / undisclosed | 4 | 25% |